Insider Transactions Reported by 20 Insiders of Intellia Therapeutics, Inc.

Symbol
NTLA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Intellia Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John M. Leonard President and CEO, Director $15,339,643 -$1,150,869 -7% 01 Mar 2026
James Basta EVP, General Counsel $2,160,621 -$112,444 -4.9% 01 Mar 2026
Glenn Goddard EVP, Chief Financial Officer $2,106,708 01 Mar 2024
Edward J. Dulac III EVP, Chief Financial Officer $2,010,427 -$163,368 -7.5% 01 Mar 2026
Fred E. Cohen Director $1,939,685 +$1,402,500 +261% 05 Jan 2026
Birgit C. Schultes EVP, Chief Scientific Officer $1,720,285 -$78,897 -4.4% 01 Mar 2026
David Lebwohl EVP, Chief Medical Officer $1,638,588 -$109,627 -6.3% 01 Mar 2026
William J. Chase Director $1,350,970 +$1,003,000 +288% 20 Aug 2025
Eliana Clark EVP, Chief Technical Officer $1,293,445 -$106,034 -7.6% 01 Mar 2026
Laura Sepp-Lorenzino EVP, Chief Scientific Officer $942,586 03 Jan 2025
Michael P. Dube VP, Chief Accounting Officer $868,392 -$84,952 -8.9% 01 Mar 2026
Derek Hicks EVP, Chief Business Officer $729,314 03 Jan 2025
Caroline Dorsa Director $373,155 14 Jun 2022
John F. Crowley Director $344,216 14 Jun 2023
Georgia Keresty Director $292,048 11 Jun 2025
Muna Bhanji Director $226,328 -$2,253 -0.99% 11 Jun 2025
Jesse Goodman Director $224,833 -$29,068 -11% 30 Jun 2025
Frank Verwiel Director $215,887 11 Jun 2025
Jean Francois Formela Director $214,210 14 Jun 2022
Brian Goff Director $194,762 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Intellia Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
James Basta NTLA Common Stock Sale -0.77% $16,688 $13.78 -1,211 156,794 02 Mar 2026 Direct
Eliana Clark NTLA Common Stock Sale -0.64% $8,364 $13.78 -607 93,864 02 Mar 2026 Direct
John M. Leonard NTLA Common Stock Award 15.4% 156,400 1,169,739 01 Mar 2026 Direct
John M. Leonard NTLA Stock Option (right to buy) Award 225,400 225,400 01 Mar 2026 Direct
James Basta NTLA Common Stock Award 41.2% 46,080 158,005 01 Mar 2026 Direct
James Basta NTLA Stock Option (right to buy) Award 65,829 65,829 01 Mar 2026 Direct
David Lebwohl NTLA Common Stock Award 8.2% 9,943 131,192 01 Mar 2026 Direct
David Lebwohl NTLA Stock Option (right to buy) Award 14,204 14,204 01 Mar 2026 Direct
Edward J. Dulac III NTLA Common Stock Award 61.5% 61,280 160,963 01 Mar 2026 Direct
Edward J. Dulac III NTLA Stock Option (right to buy) Award 87,543 87,543 01 Mar 2026 Direct
Birgit C. Schultes NTLA Common Stock Award 39.8% 39,200 137,733 01 Mar 2026 Direct
Birgit C. Schultes NTLA Stock Option (right to buy) Award 56,000 56,000 01 Mar 2026 Direct
Eliana Clark NTLA Common Stock Award 8.44% 7,353 94,471 01 Mar 2026 Direct
Eliana Clark NTLA Stock Option (right to buy) Award 10,505 10,505 01 Mar 2026 Direct
Michael P. Dube NTLA Common Stock Award 33% 17,250 69,527 01 Mar 2026 Direct
John M. Leonard NTLA Common Stock Sale -3.26% $314,485 $9.21 -34,146 1,013,339 05 Jan 2026 Direct
Birgit C. Schultes NTLA Common Stock Sale -7.95% $78,359 $9.21 -8,508 98,533 05 Jan 2026 Direct
James Basta NTLA Common Stock Sale -9.29% $95,756 $9.21 -10,397 101,528 05 Jan 2026 Direct
Fred E. Cohen NTLA Common Stock Purchase 261.1% $1,402,500 $9.35 150,000 207,453 05 Jan 2026 Direct
David Lebwohl NTLA Common Stock Sale -8.94% $109,627 $9.21 -11,903 121,249 05 Jan 2026 Direct
Eliana Clark NTLA Common Stock Sale -9.85% $87,633 $9.21 -9,515 87,118 05 Jan 2026 Direct
Edward J. Dulac III NTLA Common Stock Sale -6.01% $58,751 $9.21 -6,379 99,683 05 Jan 2026 Direct
Michael P. Dube NTLA Common Stock Sale -5.41% $27,529 $9.21 -2,989 52,277 05 Jan 2026 Direct
John M. Leonard NTLA Common Stock Options Exercise 0.82% 8,557 1,047,485 12 Dec 2025 Direct
John M. Leonard NTLA Stock Option (right to buy) Options Exercise -100% -8,557 0 12 Dec 2025 Direct
John M. Leonard NTLA Common Stock Sale -7.82% $836,384 $9.49 -88,146 1,038,928 11 Dec 2025 Direct
John M. Leonard NTLA Common Stock Options Exercise 4.64% 49,959 1,127,074 11 Dec 2025 Direct
John M. Leonard NTLA Stock Option (right to buy) Options Exercise -85.4% -49,959 8,557 11 Dec 2025 Direct
Birgit C. Schultes NTLA Common Stock Sale -0.03% $539 $17.38 -31 105,184 01 Oct 2025 Direct
Michael P. Dube NTLA Common Stock Sale -3.27% $32,518 $17.38 -1,871 55,266 01 Oct 2025 Direct
William J. Chase NTLA Common Stock Purchase 288.2% $1,003,000 $10.03 100,000 134,693 20 Aug 2025 Direct
Edward J. Dulac III NTLA Common Stock Sale -6.57% $104,617 $14.02 -7,462 106,062 23 Jul 2025 Direct
Michael P. Dube NTLA Common Stock Sale -4.2% $24,905 $9.95 -2,503 57,137 02 Jul 2025 Direct
Eliana Clark NTLA Common Stock Sale -1.06% $10,036 $9.82 -1,022 95,369 01 Jul 2025 Direct
Jesse Goodman NTLA Common Stock Sale -5.97% $14,279 $9.23 -1,547 24,359 01 Jul 2025 Direct
Jesse Goodman NTLA Common Stock Sale -5.64% $14,789 $9.56 -1,547 25,906 30 Jun 2025 Direct
Georgia Keresty NTLA Common Stock Award 33.5% 8,000 31,883 11 Jun 2025 Direct
Georgia Keresty NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
Frank Verwiel NTLA Common Stock Award 44.6% 8,000 25,948 11 Jun 2025 Direct
Frank Verwiel NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
Jesse Goodman NTLA Common Stock Award 41.1% 8,000 27,453 11 Jun 2025 Direct
Jesse Goodman NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
Brian Goff NTLA Common Stock Award 51.9% 8,000 23,409 11 Jun 2025 Direct
Brian Goff NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
Muna Bhanji NTLA Common Stock Award 41.7% 8,000 27,203 11 Jun 2025 Direct
Muna Bhanji NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
William J. Chase NTLA Common Stock Award 30% 8,000 34,693 11 Jun 2025 Direct
William J. Chase NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
Fred E. Cohen NTLA Common Stock Award 16.2% 8,000 57,453 11 Jun 2025 Direct
Fred E. Cohen NTLA Stock Option (right to buy) Award 11,450 11,450 11 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.